| What Should Multi-Unit Restaurant Operators Look for When Switching POS Systems? Lavu Publishes 2026 Buyer’s Guide |
Globe Newswire |
03/17 |
16:52 |
| Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year Results |
Globe Newswire |
03/17 |
16:50 |
| Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care |
Globe Newswire |
03/17 |
16:49 |
| Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting |
Globe Newswire |
03/17 |
16:45 |
| Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 |
Globe Newswire |
03/17 |
16:45 |
| Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA |
Globe Newswire |
03/17 |
16:35 |
| Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial |
Globe Newswire |
03/17 |
16:35 |
| Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival |
Globe Newswire |
03/17 |
16:35 |
| Sportradar to Participate in the 38th Annual Roth Conference |
Globe Newswire |
03/17 |
16:31 |
| INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ostin Technology Group Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – OST |
Globe Newswire |
03/17 |
16:31 |
| Global Extended Detection and Response (XDR) Market Size/Share Worth USD 6.1 Billion by 2034 at a 21% CAGR: Business Research Industry (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) |
Globe Newswire |
03/17 |
16:30 |
| Parsons Announces New Chief Human Resources Officer |
Globe Newswire |
03/17 |
16:30 |
| BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026 |
Globe Newswire |
03/17 |
16:30 |
| TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares |
Globe Newswire |
03/17 |
16:30 |
| Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy |
Globe Newswire |
03/17 |
16:30 |
| Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days |
Globe Newswire |
03/17 |
16:30 |
| Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 |
Globe Newswire |
03/17 |
16:30 |
| Molecular Partners to Hold Three Poster Presentations at AACR 2026 |
Globe Newswire |
03/17 |
16:30 |
| Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting |
Globe Newswire |
03/17 |
16:30 |
| Evaxion to present new data at AACR Annual Meeting |
Globe Newswire |
03/17 |
16:30 |
| Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum |
Globe Newswire |
03/17 |
16:30 |
| Ocean Power Technologies, Inc. Announces Third Quarter Fiscal 2026 Results |
Globe Newswire |
03/17 |
16:15 |
| Longeveron Announces 2025 Full Year Financial Results and Provides Business Update |
Globe Newswire |
03/17 |
16:05 |
| Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer |
Globe Newswire |
03/17 |
16:05 |
| Cibus Reports Fourth Quarter Financial Results and Provides Business Update |
Globe Newswire |
03/17 |
16:05 |
